| David Bong, MD | |
|
700 Ne 87th Ave, Vancouver, WA 98664-1913 | |
| (360) 397-1500 | |
| (360) 397-3128 |
| Full Name | David Bong |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 700 Ne 87th Ave, Vancouver, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548209653 | NPI | - | NPPES |
| 8186801 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MD00015272 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David Bong, MD 700 Ne 87th Ave, Vancouver, WA 98664-1913 Ph: (360) 397-1500 | David Bong, MD 700 Ne 87th Ave, Vancouver, WA 98664-1913 Ph: (360) 397-1500 |
News Archive
The neuropeptide αCGRP (α calcitonin gene-related peptide) works in two different ways. It leads to inflammation and dilates the blood vessels right at the release point of the nerve cells, for example in the meninges, which can trigger migraine attacks. However, it has a completely different effect on the heart, as has now been discovered by a team of researchers at the University of Zurich.
Public attitude toward COVID-19 and its treatments is more "infectious" than the disease itself, according to a new Northwestern Medicine study using Artificial Intelligence (AI) to analyze tweets about the virus.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, an antibody to interleukin-1 beta, an orphan drug for the treatment of Behcet's disease. As previously announced, the Committee for Orphan Medical Products of the European Medicines Agency has recommended the granting of orphan medicinal product designation for XOMA 052 for the same indication in the European Union.
Alkermes, Inc. today announced the initiation of a multidose phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC). The randomized, double-blind, placebo-controlled, repeat-dose study will assess the safety, tolerability and pharmacokinetics of daily oral administration of two dose levels of ALKS 37 for a seven day period in approximately 24 healthy volunteers.
Life Time Fitness, Inc., The Healthy Way of Life Company, today reported its financial results for the first quarter ended March 31, 2011.
› Verified 9 days ago
Kanuboddu Nagarjuna Reddy, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 700 Ne 87th Ave Ste 220, Vancouver, WA 98664 Phone: 360-882-2778 | |
Dr. David Steiger, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 505 Ne 87th Ave Ste 301, Vancouver, WA 98664 Phone: 360-514-7374 Fax: 360-514-7384 | |
Phillip M Cullison Bonner, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2211 Ne 139th St, Vancouver, WA 98686 Phone: 360-487-1000 | |
Louise M Schultz, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 700 Ne 87th Ave, Vancouver, WA 98664 Phone: 360-882-2778 | |
Marissa Krienke, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 700 Ne 87th Ave Ste And240, Vancouver, WA 98664 Phone: 360-882-2778 | |
Joel David Mclarry, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 700 Ne 87th Ave, Suite 210, Vancouver, WA 98664 Phone: 360-882-2778 | |
Dr. Samuel Everett George, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 19005 Se 34th St Bldg 3, Vancouver, WA 98683 Phone: 360-726-6720 Fax: 360-726-6729 |